RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Validation of the Depression and Family Functioning Scale (Dffs)
Francois, C., Danchenko, N., Williams, V., Nelsen, L., Yarr, S., DiBenedetti, D., & Lancon, C. (2015). Validation of the Depression and Family Functioning Scale (Dffs). Value in Health, 18(3), A24-A24. https://doi.org/10.1016/j.jval.2015.03.150
Patient-reported outcomes (PROs) are necessary to assess disease impacts from the patient’s perspective. In line with the Food and Drug Administration’s (FDA’s) guidance on PROs, the Depression and Family Functioning Scale (DFFS) was developed to assess the impact of major depressive disorder (MDD) on family functioning. Psychometric analyses were conducted to establish the reliability, validity, and responsiveness of the DFFS according to the FDA PRO guidance.
